Ovarian cancer: involvement of the matrix metalloproteinases

被引:83
作者
Al-Alem, Linah [1 ]
Curry, Thomas E., Jr. [1 ]
机构
[1] Univ Kentucky, Med Ctr, Dept Obstet & Gynecol, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
PROGNOSTIC-SIGNIFICANCE; INCESSANT OVULATION; CLINICAL-RELEVANCE; PROMOTES INVASION; TISSUE INHIBITORS; SIGNALING SYSTEM; CARCINOMA CELLS; MESSENGER-RNA; EXPRESSION; ACTIVATION;
D O I
10.1530/REP-14-0546
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Ovarian cancer is the leading cause of death from gynecologic malignancies. One of the reasons for the high mortality rate associated with ovarian cancer is its late diagnosis, which often occurs after the cancer has metastasized throughout the peritoneal cavity. Cancer metastasis is facilitated by the remodeling of the extracellular tumor matrix by a family of proteolytic enzymes known as the matrix metalloproteinases (MMPs). There are 23 members of the MMP family, many of which have been reported to be associated with ovarian cancer. In the current paradigm, ovarian tumor cells and the surrounding stromal cells stimulate the synthesis and/or activation of various MMPs to aid in tumor growth, invasion, and eventual metastasis. The present review sheds light on the different MMPs in the various types of ovarian cancer and on their impact on the progression of this gynecologic malignancy.
引用
收藏
页码:R55 / R64
页数:10
相关论文
共 93 条
  • [1] Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer
    Acar, Ayla
    Onan, Anil
    Coskun, Ugur
    Uner, Aytug
    Bagriacik, Umit
    Atalay, Funda
    Unsal, Diclehan Kilic
    Guner, Haldun
    [J]. MEDICAL ONCOLOGY, 2008, 25 (03) : 279 - 283
  • [2] Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
    Agarwal, Anika
    Covic, Lidija
    Sevigny, Leila M.
    Kaneider, Nicole C.
    Lazarides, Katherine
    Azabdaftari, Gissou
    Sharifi, Sheida
    Kuliopulos, Athan
    [J]. MOLECULAR CANCER THERAPEUTICS, 2008, 7 (09) : 2746 - 2757
  • [3] Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
    Agarwal, Anika
    Tressel, Sarah L.
    Kaimal, Rajani
    Balla, Marianthi
    Lam, Francis H.
    Covic, Lidija
    Kuliopulos, Athan
    [J]. CANCER RESEARCH, 2010, 70 (14) : 5880 - 5890
  • [4] Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP10
    Al-Alem, Linah F.
    McCord, Lauren A.
    Southard, R. Chase
    Kilgore, Michael W.
    Curry, Thomas E., Jr.
    [J]. BIOLOGY OF REPRODUCTION, 2013, 89 (03)
  • [5] Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer
    Arechavaleta-Velasco, Fabian
    Cuevas-Antonio, Rocio
    Dominguez-Lopez, Pablo
    Estrada-Moscoso, Isaias
    Shahram Imani-Razavi, Fazlollah
    Zeferino-Toquero, Moises
    Diaz-Cueto, Laura
    [J]. MEDICAL ONCOLOGY, 2014, 31 (08)
  • [6] Behrens P, 2001, INT J MOL MED, V8, P149
  • [7] Belotti D, 2003, CANCER RES, V63, P5224
  • [8] Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1
  • [9] Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome
    Berchuck, Andrew
    Iversen, Edwin S.
    Luo, Jingqin
    Clarke, Jennifer P.
    Horne, Hisani
    Levine, Douglas A.
    Boyd, Jeff
    Alonso, Miguel A.
    Secord, Angeles Alvarez
    Bernardini, Marcus Q.
    Barnett, Jason C.
    Boren, Todd
    Murphy, Susan K.
    Dressman, Holly K.
    Marks, Jeffrey R.
    Lancaster, Johnathan M.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (07) : 2448 - 2455
  • [10] MATRIX METALLOPROTEINASES - A REVIEW
    BIRKEDALHANSEN, H
    MOORE, WGI
    BODDEN, MK
    WINDSOR, LJ
    BIRKEDALHANSEN, B
    DECARLO, A
    ENGLER, JA
    [J]. CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) : 197 - 250